Mucoid impaction: An unusual form of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis

Cakir E., Uyan Z. S., Hamutcu Ersu R., Karadag B., Karakoc F., Dagli E.

PEDIATRIC PULMONOLOGY, cilt.41, sa.11, ss.1103-1107, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 11
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1002/ppul.20499
  • Dergi Adı: PEDIATRIC PULMONOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1103-1107
  • Anahtar Kelimeler: allergic broncho-pulmonary aspergillosis, mucoid impaction, cystic fibrosis, child, corticosteroids, cataract, PULMONARY ASPERGILLOSIS, INVASIVE ASPERGILLOSIS, ITRACONAZOLE, DIAGNOSIS, THERAPY, SPECTRUM, PREVALENCE, MANAGEMENT, ATOPY
  • Marmara Üniversitesi Adresli: Evet

Özet

We reported a child with cystic fibrosis (CF) who developed mucoid impaction related to allergic bronchopulmonary aspergillosis (ABPA). This is the first reported case of mucoid impaction related to ABPA in CF described to date in the literature. The case was successfully treated by corticosteroids and itraconazole therapy, but relapsed 6 months later. During exacerbation therapy, cataract formation complicated the corticosteroid treatment. We want to emphasize that 6-months therapy may be inadequate for the treatment of ABPA, and it is important to monitor for possible complications of corticosteroids therapy.